CEACAM16 Antibodies

Santa Cruz Biotechnology delivers a wide array of CEACAM16 monoclonal antibodies for research applications. CEACAM16 monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CEACAM16, a member of the carcinoembryonic antigen (CEA) family, plays a significant role in cell adhesion and signaling processes. Expression patterns of CEACAM16 are associated with various physiological and pathological conditions, making it an important target for understanding cellular interactions and disease mechanisms. Research focusing on CEACAM16 can provide insights into cancer biology and potential therapeutic strategies. CEACAM16 monoclonal antibodies enable precise detection and characterization of cellular pathways and molecular mechanisms. Investigating CEACAM16 expression and function contributes to understanding its role in health and disease. The specificity and reliability of CEACAM16 monoclonal antibodies from Santa Cruz Biotechnology support researchers in advancing scientific knowledge and developing new therapeutic approaches.